CureVac raises EUR 80 million in D round

CureVac GmbH (Tuebingen, Germany) raised EUR 80 million ($104.9 million) in a series D round from existing investor dievini Hopp BioTech. CureVac is developing mRNA vaccines for cancer and prophylacti...